- Home
- BUDA vs FATE Comparison
BUDA vs FATE Comparison
Compare BUDA & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BUDA | FATE |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | United States | United States |
| Employees | 39 | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.2M | 125.6M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | BUDA | FATE |
|---|---|---|
| Price | $9.63 | $2.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $14.00 | $4.10 |
| AVG Volume (30 Days) | 3.2K | ★ 1.7M |
| Earning Date | 03-26-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.88 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,646,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $24.42 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.61 | $0.91 |
| 52 Week High | $10.70 | $1.94 |
Technical Indicators
Market Signals| Indicator | BUDA | FATE |
|---|---|---|
| Relative Strength Index (RSI) | 47.35 | 82.59 |
| Support Level | $8.92 | $0.99 |
| Resistance Level | $10.53 | N/A |
| Average True Range (ATR) | 0.53 | 0.12 |
| MACD | -0.07 | 0.07 |
| Stochastic Oscillator | 43.78 | 91.71 |
Price Performance
Historical ComparisonAbout BUDA Buda Juice Inc. Common Stock
Buda Juice Inc operates in a beverage industry, focused on fresh, cold-crafted juice production for business-to-business (B2B) distribution. The Company mostly utilizes third-party delivery systems and operates within the State of Texas serving large, national chain grocery stores. It is pioneering a new category in beverages-UltraFresh juice-offering cold-crafted citrus-based drinks that are never heat-treated, pasteurized, never HPP- processed, never UV- treated and always cold.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.